Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ECHA InfoCard | 100.000.916 |
Chemical and physical data | |
Formula | C17H25NO2 |
Molar mass | 275.392 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Proheptazine is an opioid analgesic related to pethidine. It was invented in the 1960s. [2]
Proheptazine produces similar effects to other opioids, [3] including analgesia, sedation, euphoria, dizziness and nausea.
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9643 and a 2013 annual aggregate manufacturing quota of zero. The salts in use are the citrate (free base conversion ratio 0.589), hydrobromide (0.773), and hydrochloride (0.883). [4] [5]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ECHA InfoCard | 100.000.916 |
Chemical and physical data | |
Formula | C17H25NO2 |
Molar mass | 275.392 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Proheptazine is an opioid analgesic related to pethidine. It was invented in the 1960s. [2]
Proheptazine produces similar effects to other opioids, [3] including analgesia, sedation, euphoria, dizziness and nausea.
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9643 and a 2013 annual aggregate manufacturing quota of zero. The salts in use are the citrate (free base conversion ratio 0.589), hydrobromide (0.773), and hydrochloride (0.883). [4] [5]